[Internal mammary chain irradiation in breast cancer: state of the art].
Radiation therapy has a major role in the management of infiltrative breast cancers. However, there is no consensus for the prophylactic treatment of the internal mammary chain (IMC), with strategies that show strong differences according to centers and physicians. Indications for internal mammary chain radiotherapy are debated, since this treatment significantly increases the dose delivered to the heart and leads to potential technical difficulties. Important prospective data recently suggested that internal mammary chain radiotherapy would not be necessary, even in cases of internal or central tumor locations, or in patients with positive axillary lymph nodes. Although these data warrant confirmation by two other prospective trials, there is evidence that the indications for internal mammary chain radiotherapy should be careful and that high quality techniques should be used for decreasing the dose delivered to the heart. This review of literature presents the state of art on the radiotherapy of internal mammary chain, with special focus on the indications, techniques, and potential toxicity.
Unité de Curiethérapie, Département de Radiothérapie, Institut de Cancérologie de la Loire, 108 bis, avenue Albert-Raimond, BP 60008, 42271 Saint-Priest-en-Jarez cedex, France.
P
P
Auberdiac
L
L
Cartier
C
C
Chargari
N-H
NH
Hau Desbat
A
A
Zioueche
A
A
Mélis
Y-M
YM
Kirova
G
G
de Laroche
N
N
Magné
D001940:Breast; D001943:Breast Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008198:Lymph Nodes; D015182:Lymphatic Irradiation / Q000379:methods*